| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/19/2001 | US20010000326 Extracting flowering top of Hypercium perforatum (St.-Johns-wort) with alcohol or acetone solvent, filtering, concetrating then diluting the extract with water or water-alcohol solvent, then extracting with aliphatic ester |
| 04/19/2001 | DE19950017A1 Emulsifier mixture of high stability, useful in pharmaceutical and cosmetic compositions, prepared by reaction of fatty acid, sugar alcohol and glycerine carbonate |
| 04/19/2001 | DE19949897A1 Shaped article, e.g. in stick form, for controlled release of drugs in wounds or body cavities, comprising hydrophilic outer phase, lipophilic inner phase and drug, e.g. antibiotic |
| 04/19/2001 | DE19948417A1 Imidazol-Derivate und ihre Verwendung als Arzneimittel Imidazole derivatives and their use as medicaments |
| 04/19/2001 | DE19947373A1 Combination preparation comprising tocopherol and magnesium ascorbate for treatment and prevention of conditions resulting from oxidative stress |
| 04/19/2001 | DE19545327C2 Verfahren zur Herstellung von hydrophobierten resorbierbaren Polyestern und deren Verwendung A process for the production of hydrophobicized resorbable polyesters and their use |
| 04/19/2001 | DE10023699A1 Retarded release tramadol dosage form, useful e.g. for treating pain, coughs or urinary incontinence, comprising tramadol saccharinate in retarding coating, e.g. of poly(meth)acrylate |
| 04/19/2001 | CA2399093A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | CA2389652A1 Archaeosomes as immunomodulating carriers for acellular vaccines to induce cytotoxic t lymphocyte(ctl) responses and protect the vaccinated host against intracellular pathogens and cancer |
| 04/19/2001 | CA2388053A1 Cationic dosper virosomes |
| 04/19/2001 | CA2387621A1 Extended release formulations of erythromycin derivatives |
| 04/19/2001 | CA2387212A1 Dry powder inhalation and a method for the preparation thereof |
| 04/19/2001 | CA2387145A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | CA2386164A1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | CA2386151A1 Reactive polymeric valve, dispensing devices and methods using same |
| 04/19/2001 | CA2385449A1 Medicament delivery device with moisture resistant coating |
| 04/19/2001 | CA2385027A1 Closed exchange system |
| 04/19/2001 | CA2383970A1 Topical nasal treatment using desloratadine |
| 04/19/2001 | CA2354558A1 Oral pharmaceutical composition |
| 04/18/2001 | EP1092434A1 Novel composition containing lansoprazole and process for its preparation |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1092430A1 Non-chlorofluorocarbon aerosol formulations |
| 04/18/2001 | EP1092429A1 Pharmaceutical preparations for drugs of low solubility |
| 04/18/2001 | EP1091775A1 Diphasic injection composition, in particular useful in reparative and plastic surgery |
| 04/18/2001 | EP1091761A1 Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| 04/18/2001 | EP1091760A1 Pharmaceutical composition containing an ester or amide pla2 inhibitor |
| 04/18/2001 | EP1091755A1 Particulate delivery systems and methods of use |
| 04/18/2001 | EP1091747A2 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions |
| 04/18/2001 | EP1091746A1 Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions |
| 04/18/2001 | EP1091732A1 Effervescent drug delivery system for oral administration |
| 04/18/2001 | EP1091731A1 Anti-inflammatory pharmaceutical formulations |
| 04/18/2001 | EP1091730A1 Utilization of growth factors for the production of medicaments |
| 04/18/2001 | EP1091729A1 Microparticle formulation for inhalation |
| 04/18/2001 | EP1091703A2 Veterinary delivery device and method |
| 04/18/2001 | EP1091659A1 Oral form of administration |
| 04/18/2001 | EP0720471B1 Hydrophobic polymeric microparticles |
| 04/18/2001 | EP0683804B1 Methods of polymer impregnation |
| 04/18/2001 | EP0546160B1 Method of reversing local anesthesia and reagent system therefor |
| 04/18/2001 | CN1291989A Substance having steroid-like structure, process for production thereof and antitumor agents containing same |
| 04/18/2001 | CN1291897A Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 04/18/2001 | CN1291888A Sustained-release preparation for AII antagonist, production and use thereof |
| 04/18/2001 | CN1291887A Stable shaped particles of crystalline organic compounds |
| 04/18/2001 | CN1291886A Formulations |
| 04/18/2001 | CN1291506A Exterior-applied medicine for preventing and treating mastopathy and its preparing process |
| 04/18/2001 | CN1291475A Cell-protecting amifostine and its preparing process |
| 04/18/2001 | CN1291474A Taxusol-lipid composition and its preparing process |
| 04/18/2001 | CN1064680C Process for preparing magnesium omeprazole |
| 04/18/2001 | CN1064549C Chinese medicinal pills for treating catarct and its prodn. method |
| 04/18/2001 | CN1064548C Capsule for promoting male sexual function and preparation process |
| 04/18/2001 | CN1064547C Capsule for treating prostate diseases and preparation process |
| 04/18/2001 | CN1064546C Capsule for treating pointed condyloma and preparation process |
| 04/18/2001 | CN1064537C Skin absorptive antiviral drug acyclovir |
| 04/18/2001 | CN1064536C Medicine for curing IV phase carcinoma of stomach |
| 04/18/2001 | CN1064535C Medicinal powder for treatment for chronic ulcerative colitis |
| 04/18/2001 | CN1064534C Medicine for skin disease |
| 04/18/2001 | CN1064531C Process for preparation of injectable ready-to use solution containing antitumor anthracycline glycoside |
| 04/17/2001 | US6218440 Hydrophilic polymeric material and method of preparation |
| 04/17/2001 | US6218428 Ophthalmic composition |
| 04/17/2001 | US6218409 Administering insulin sensitivity enhancer in combination with an aldose reductase inhibitor for reducing side effects of diabetic drugs |
| 04/17/2001 | US6218399 Modifying the 20 position of camptothecin to form a compound which is low toxicity used in cancer therapy |
| 04/17/2001 | US6218390 Morpholinone and morpholine derivatives and uses thereof |
| 04/17/2001 | US6218375 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin and method |
| 04/17/2001 | US6218373 Formulations containing hyaluronic acid |
| 04/17/2001 | US6218166 Non-covalently incorporated adjuvant such as monophosphoryl lipid a (mpl) or a teichoic acid which stimulates an immune response; administering with cancer cells to treat cancer |
| 04/17/2001 | US6218016 Lubricious, drug-accommodating coating |
| 04/17/2001 | US6217916 Immobilized-cell carrageenan bead production and a brewing process utilizing carrageenan bead immobilized yeast cells |
| 04/17/2001 | US6217912 Polyester analogue of poly-L-lysine as a soluble, biodegradable gene delivery carrier |
| 04/17/2001 | US6217911 Blend containing poly(lactide/glycolide) polymer |
| 04/17/2001 | US6217910 Melt granulation of a powdered low melting oily compound and powdered drug |
| 04/17/2001 | US6217909 Pharmaceutical excipient having improved compressibility |
| 04/17/2001 | US6217908 Administering to mucous membranes |
| 04/17/2001 | US6217907 Directly compressible high load acetaminophen formulations |
| 04/17/2001 | US6217906 Drug delivery |
| 04/17/2001 | US6217905 Antiparkinson dosage form |
| 04/17/2001 | US6217904 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant |
| 04/17/2001 | US6217903 Sustained release polymer blend for pharmaceutical applications |
| 04/17/2001 | US6217902 Soft gelatin capsules containing particulate material |
| 04/17/2001 | US6217901 Polymerizing polymer and liposomes |
| 04/17/2001 | US6217900 Vesicular complexes and methods of making and using the same |
| 04/17/2001 | US6217899 Liposomes preparation method and plant |
| 04/17/2001 | US6217897 Anhydrous spreadable mucoadhesive |
| 04/17/2001 | US6217896 Conjunctival inserts for topical delivery of medication or lubrication |
| 04/17/2001 | US6217895 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 04/17/2001 | US6217894 Addition polymer |
| 04/17/2001 | US6217893 Sustained-release compositions and method for preparing same |
| 04/17/2001 | US6217886 Materials and methods for making improved micelle compositions |
| 04/17/2001 | US6217874 Glyceride mixture |
| 04/17/2001 | US6217860 Supplying adenoviral vector into tumor |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/17/2001 | US6216707 Use of at least an Irvingia gabonensis extract in a cosmetic and/or pharmaceutical product |
| 04/17/2001 | US6216699 Antimicrobial containing solventless hot melt adhesive composition |
| 04/17/2001 | CA2213861C Method for loading lipid vesicles |
| 04/17/2001 | CA2188284C Group a streptococcal polysaccharide immunogenic compositions and methods |
| 04/17/2001 | CA2157003C Hormone replacement therapy |
| 04/17/2001 | CA2074824C Process for depleting viruses in solutions and for determining the depletion rate of the viruses |
| 04/17/2001 | CA2055493C Antineoplastic solution and method for treating neoplasms |
| 04/12/2001 | WO2001025491A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 04/12/2001 | WO2001025490A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 04/12/2001 | WO2001025414A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | WO2001025402A1 Isolation of precursor cells and their use for tissue repair |